Lehrstuhl für Haut- und Geschlechtskrankheiten

Hazard rates and implications for follow-up schedules of melanoma patients with 0.8–1.0 mm tumor thickness: An analysis of the German Central Malignant Melanoma Registry in 12,132 patients (2025) Aebischer V, Nanz L, Amaral T, Berking C, Eigentler T, Flatz L, Forschner A, et al. Journal article Multiple squamous cell carcinomas arising in linear porokeratosis Multiple Plattenepithelkarzinome auf einer linearen Porokeratose (2025) Busch D, Berking C, Schliep S, Erfurt-Berge C Journal article Implications for medication safety and adherence in dermato-oncology: The AMBORA care program for oral antitumor therapeutics (2025) Cuba L, Dörje F, Kramer R, Dürr P, Erdmann M, Fromm M, Berking C, Geßner K Journal article Long-term follow-up of a randomized, double-blind, phase III, multi-centre study to evaluate the safety and efficacy of field-directed photodynamic therapy (PDT) of mild to moderate actinic keratosis using BF-200 ALA versus placebo and the BF-RhodoLED® lamp. (2025) Reinhold U, Philipp-Dormston WG, Dirschka T, Ostendorf R, Aschoff R, Berking C, Jäger A, et al. Journal article Corrigendum: Advancement and independent validation of a deep learning-based tool for automated scoring of nail psoriasis severity using the modified nail psoriasis severity index (Frontiers in Medicine, (2025), 12, (1574413), 10.3389/fmed.2025.1574413) (2025) Kemenes S, Chang L, Schlereth M, Corte G, Noversa de Sousa R, Minopoulou I, Fenzl P, et al. Journal article, Erratum Long-term follow-up of real-world adjuvant anti-PD1 checkpoint inhibition and targeted therapy in stage III melanoma patients (2025) Lodde GC, Hassel JC, von Wasielewski I, Meier F, Mohr P, Kähler K, Hauschild A, et al. Journal article Pharmacodynamic effect of mTOR inhibition-based immunosuppressive therapy on dendritic cell and natural killer cell subsets after renal transplantation (2025) Weber S, Wei X, Chen G, Yankouskaya K, Yin D, Allabauer I, Jobst-Schwan T, et al. Journal article Advancement and independent validation of a deep learning-based tool for automated scoring of nail psoriasis severity using the modified nail psoriasis severity index (2025) Kemenes S, Liu C, Schlereth M, Noversa de Sousa R, Minopoulou I, Fenzl P, Corte G, et al. Journal article Secondary resistance to sonidegib is rare in locally advanced basal cell carcinoma (2025) Muñoz Couselo E, Berking C, Baurain JF, Martelli S, Arntz R, Savoia P Journal article Treatment at the end of life in patients with advanced melanoma. A multicenter DeCOG study of 1067 patients from the prospective skin cancer registry ADOReg. (2025) Forschner A, Kähler KC, Gschnell M, Langan EA, Weishaupt C, Meiss F, Thoms KM, et al. Journal article